6
PYFA0206.TXT

PYFA
Pyridam Farma Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 30-Jun-2002
Fiscal Year Ends            : Dec
Months Covered in Income St : 6

Summary of Balance Sheet
  Receivables               :       7,912,274.96
  Inventories               :       6,535,645.38
  Current Assets            :      18,890,261.43
  Fixed Assets              :      56,307,177.89
  Other Asstes              :               0.00
  Total Assets              :      75,630,733.49
  Current Liabilities       :       8,659,536.26
  Longterm Liabiities       :       4,878,714.34
  Total Liabilities         :      13,538,250.59
  Authorized                :       1,600,000.00
  Paid-up Capital           :      52,000,000.00
  Par Value                 :                100
  Paid-up Capital Shares    :         520,000.00
  Retained Earnings         :      11,043,404.40
  Total Equity              :      62,092,482.90
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :      13,153,503.92
  Cost of Good Sold         :       4,701,282.72
  Gross Profit              :       8,452,221.20
  Operating Profit          :       2,467,709.26
  Other Income              :        -208,289.67
  Eearning Before Tax       :       2,259,419.58
  Tax                       :         690,886.11
  Net Income                :       1,568,533.47
  Closing Price             :             300.00

Per Share Data (Rp)
  Eps                       :               6.03
  Book Value                :             119.41

Financial Ratios
  Debt Equity Ratio (X)     :                .22
  Roa (%)                   :               4.15
  Roe (%)                   :               5.05
  Npm (%)                   :              11.92
  Opm (%)                   :              18.76

Cash Flow
  CF from Operating Activities                        :       4,375,397.89
  CF from Investing Activities                        :      -1,672,427.26
  CF from Financing Activities                        :      -4,200,511.44
  Net Increase in Cash & Cash Equivalent              :      -1,497,540.81
  Cash & Cash Equivalent at The Beginning of The Year :       5,478,369.76
  Cash & Cash Equivalent at The End of The Year       :       3,980,828.95

 
 
 
